New York Life Investment Management’s CSG Systems International CSGS Stock Holding History

New York Life Investment Management’s Portfolio CSGS Stock Details CSGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-43,382	Closed	-$3.47M	–	785
2026 Q1	$3.47M	Buy	43,382 +7,652	+21%	+$609K	0.03%	416
2025 Q4	$2.74M	Buy	+35,730	New	+$2.64M	0.02%	456
2024 Q2	–	Sell	-7,089	Closed	-$365K	–	977
2024 Q1	$365K	Buy	+7,089	New	+$368K	﹤0.01%	1097
2023 Q1	–	Sell	-8,925	Closed	-$511K	–	1248
2022 Q4	$511K	Buy	8,925 +1,007	+13%	+$59.2K	0.01%	915
2022 Q3	$419K	Buy	7,918 +582	+8%	+$33.9K	0.01%	904
2022 Q2	$438K	Buy	+7,336	New	+$444K	0.01%	828

Other funds holding CSGS

MIM

Morningstar Investment Management Chicago, Illinois $1.62B AUM 13.96% 1-Year Est. Return

Curat Global Springfield, New Hampshire $122M AUM 46.06% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

New York Life Investment Management's CSGS Position: Q2 2026 in Review

New York Life Investment Management sold out of CSG Systems International (CSGS) in Q2 2026, closing a stake of 43,382 shares — an estimated $3.47M sold.

New York Life Investment Management first reported a position in CSGS in Q2 2022 and held it in 6 quarters. The position peaked at $3.47M in Q1 2026. 3 funds tracked by Wall St. Rank hold CSGS as of Q2 2026.

New York Life Investment Management reported no remaining CSG Systems International position as of Q2 2026 after selling out during the quarter.
New York Life Investment Management sold 43,382 CSG Systems International shares in Q2 2026, an estimated $3.47M.
New York Life Investment Management first reported a position in CSG Systems International in Q2 2022 and held it in 6 quarters.
New York Life Investment Management's CSG Systems International position peaked at $3.47M in Q1 2026.
3 funds tracked by Wall St. Rank held CSG Systems International as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.